Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.
Department of Urology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
World J Urol. 2018 Jul;36(7):1093-1101. doi: 10.1007/s00345-018-2241-7. Epub 2018 Feb 27.
To evaluate oncologic outcomes and management of patients with microscopic positive surgical margin (PSM) after partial nephrectomy (PN) for renal cell carcinoma (RCC).
We reviewed our database to identify patients who underwent PN between 1990 and 2015 for RCC and had PSM on final pathology. A 1:3 matching was performed to a negative surgical margin (NSM) cohort. Kaplan-Meier method and log-rank test were used to estimate survival and differences in outcomes, respectively. Cox proportional hazards models were conducted to estimate the Hazards ratio.
A total of 2297 patients underwent PN at our institution, of which 1863 (81%) had RCC. Microscopic PSM was found in 34 (1.8%) RCC patients who were matched to 100 patients with NSM. Of these 34 patients, local recurrence (n = 4), distant kidney recurrences (n = 4), and metastases (n = 5) developed during a median follow-up of 62 months. Bilateral tumors/tumors in a solitary kidney (n = 12/13, 92%), and multifocal tumors (n = 7/13, 54%) were found in patients who developed recurrence/metastasis. PSM patients were at a higher risk of shorter overall survival (p = 0.001), local recurrence-free survival (p = 0.003), distant recurrence-free survival (p = 0.032) and metastasis-free survival (p = 0.018). There was statistically significant association between PSM and bilateral tumors, prior treated RCC at presentation and higher nephrometry score in multivariable model.
There was a low rate of microscopic PSM in our large cohort of patients undergoing PN despite tumor complexity. Higher nephrometry score, bilateral tumors, and prior treated RCC independently predicted PSM which showed worse survival, recurrence and metastasis compared to patients with NSM.
评估肾细胞癌(RCC)患者行部分肾切除术(PN)后肿瘤切缘阳性(PSM)的肿瘤学结果和处理方法。
我们回顾了数据库,以确定 1990 年至 2015 年间接受 PN 治疗且最终病理报告显示 PSM 的 RCC 患者。对 PSM 患者进行了 1:3 配对以匹配阴性切缘(NSM)患者。使用 Kaplan-Meier 方法和对数秩检验分别估计生存和结果差异,使用 Cox 比例风险模型估计风险比。
我们机构共有 2297 例患者接受了 PN,其中 1863 例(81%)患有 RCC。34 例 RCC 患者的病理报告显示存在显微镜下 PSM,与 100 例 NSM 患者相匹配。在这 34 例患者中,4 例出现局部复发,4 例出现远处肾脏复发,5 例出现转移,中位随访时间为 62 个月。在发生复发/转移的患者中,双侧肿瘤/孤立肾中的肿瘤(n=12/13,92%)和多灶性肿瘤(n=7/13,54%)。PSM 患者的总生存率(p=0.001)、局部无复发生存率(p=0.003)、远处无复发生存率(p=0.032)和无转移生存率(p=0.018)均较短。在多变量模型中,PSM 与双侧肿瘤、初诊时已治疗的 RCC 和更高的肾肿瘤评分有统计学显著关联。
尽管肿瘤复杂性较高,但在我们的大型 PN 患者队列中,PSM 的发生率较低。更高的肾肿瘤评分、双侧肿瘤和已治疗的 RCC 独立预测 PSM,与 NSM 患者相比,PSM 患者的生存率、复发率和转移率更差。